Myocardial fibrosis seen through the lenses of T-cell biology

Journal of Molecular and Cellular Cardiology

Volumn 92, Issue , 2016, Pages 41-45

  Ramos, Gustavo ^a   Hofmann, Ulrich ^a,b   Frantz, Stefan ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Healing; Myocardial fibrosis; Myocardial infarction; T cells

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OSTEOPONTIN; STROMELYSIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DISEASE COURSE; EXTRACELLULAR MATRIX; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SCAR FORMATION; T LYMPHOCYTE; TISSUE REPAIR; ANIMAL; CARDIAC MUSCLE; CARDIOMYOPATHY; HEART INFARCTION; HEART VENTRICLE REMODELING; MACROPHAGE; METABOLISM; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; WOUND HEALING;

ANIMALS; CARDIOMYOPATHIES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; MACROPHAGES; MYOCARDIAL INFARCTION; MYOCARDIUM; T-LYMPHOCYTE SUBSETS; VENTRICULAR REMODELING; WOUND HEALING;

EID: 84956607670     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.01.018     Document Type: Review

References (54)

1. Wei L. Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis. Exp. Mol. Pathol. 2011, 90(1):74-78.
2. Steg P.G., James S.K., Atar D., Badano L.P., Blomstrom-Lundqvist C., Borger M.A., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2012, 33(20):2569-2619.
3. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic Heart failure 2012 of the European society Of cardiology. developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2012, 33(14):1787-1847.
4. Frangogiannis N.G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 2014, 11(5):255-265.
5. Hulsmans M., Sam F., Nahrendorf M. Monocyte and macrophage contributions to cardiac remodeling. J. Mol. Cell. Cardiol. 2015, (pii: S0022-2828(15)30120-6, Epub ahead of print). 10.1016/j.yjmcc.2015.11.015.
6. Turner N.A. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). J. Mol. Cell. Cardiol. 2015, (pii: S0022-2828(15)30107-3, Epub ahead of print). 10.1016/j.yjmcc.2015.11.002.
7. Hofmann U., Frantz S. How can we cure a heart "in flame"? A translational view on inflammation in heart failure. Basic Res. Cardiol. 2013, 108(4):356.
8. Hofmann U., Frantz S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ. Res. 2015, 116(2):354-6759.
9. Hofmann U., Frantz S. Role of T-cells in myocardial infarction. Eur. Heart J. 2015, (pii: ehv639, Epub ahead of print).
10. Costa R.A., Ruiz-de-Souza V., Azevedo G.M., Gava E., Kitten G.T., Vaz N.M., et al. Indirect effects of oral tolerance improve wound healing in skin. Wound Repair Regen. 2011, 19(4):487-497.
11. Burzyn D., Kuswanto W., Kolodin D., Shadrach J.L., Cerletti M., Jang Y., et al. A special population of regulatory T cells potentiates muscle repair. Cell 2013, 155(6):1282-1295.
12. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 1999, 5(1):49-55.
13. Walsh J.T., Hendrix S., Boato F., Smirnov I., Zheng J., Lukens J.R., et al. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. J. Clin. Invest. 2015, 125(6):2547.
14. Wilson M.S., Wynn T.A. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009, 2(2):103-121.
15. Mescher A.L., Neff A.W. Limb regeneration in amphibians: immunological considerations. ScientificWorldJournal 2006, 6(Suppl. 1):1-11.
16. Borthwick L.A., Wynn T.A., Fisher A.J. Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta 2013, 1832(7):1049-1060.
17. Borthwick L.A., Barron L., Hart K.M., Vannella K.M., Thompson R.W., Oland S., et al. Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol. 2015.
18. Chiaramonte M.G., Donaldson D.D., Cheever A.W., Wynn T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 1999, 104(6):777-785.
19. Sandler N.G., Mentink-Kane M.M., Cheever A.W., Wynn T.A. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 2003, 171(7):3655-3667.
20. Yu Q., Horak K., Larson D.F. Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 2006, 48(1):98-104.
21. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8(12):958-969.
22. Mills C.D., Kincaid K., Alt J.M., Heilman M.J., Hill A.M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164(12):6166-6173.
23. Yoshizaki A., Yanaba K., Iwata Y., Komura K., Ogawa A., Akiyama Y., et al. Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J. Immunol. 2010, 185(4):2502-2515.
24. Gurujeyalakshmi G., Giri S.N. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp. Lung Res. 1995, 21(5):791-808.
25. Oldroyd S.D., Thomas G.L., Gabbiani G., El Nahas A.M. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 1999, 56(6):2116-2127.
26. Yu Q., Watson R.R., Marchalonis J.J., Larson D.F. A role for T lymphocytes in mediating cardiac diastolic function. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(2):H643-H651.
27. Feng W., Li W., Liu W., Wang F., Li Y., Yan W. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp. Mol. Pathol. 2009, 87(3):212-218.
28. Wilson M.S., Madala S.K., Ramalingam T.R., Gochuico B.R., Rosas I.O., Cheever A.W., et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17 A dependent. J. Exp. Med. 2010, 207(3):535-552.
29. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 2007, 13(3):108-116.
30. Arpaia N., Green J.A., Moltedo B., Arvey A., Hemmers S., Yuan S., et al. A distinct function of regulatory T Cells in tissue protection. Cell 2015, 162(5):1078-1089.
31. Krishnamurthy P., Thal M., Verma S., Hoxha E., Lambers E., Ramirez V., et al. Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ. Res. 2011, 109(11):1280-1289.
32. Weirather J., Hofmann U.D., Beyersdorf N., Ramos G.C., Vogel B., Frey A., et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ. Res. 2014, 115(1):55-67.
33. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74(2):184-195.
34. Ramos G.C., Dalbo S., Leite D.P., Goldfeder E., Carvalho C.R., Vaz N.M., et al. The autoimmune nature of post-infarct myocardial healing: oral tolerance to cardiac antigens as a novel strategy to improve cardiac healing. Autoimmunity 2012, 45(3):233-244.
35. Hofmann U., Beyersdorf N., Weirather J., Podolskaya A., Bauersachs J., Ertl G., et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 2012, 125(13):1652-1663.
36. Goodchild T.T., Robinson K.A., Pang W., Tondato F., Cui J., Arrington J., et al. Bone marrow-derived B cells preserve ventricular function after acute myocardial infarction. JACC Cardiovasc. Interv. 2009, 2(10):1005-1016.
37. Curato C., Slavic S., Dong J., Skorska A., Altarche-Xifro W., Miteva K., et al. Identification of noncytotoxic and IL-10-producing CD8 + AT2R+ T cell population in response to ischemic heart injury. J. Immunol. 2010, 185(10):6286-6293.
38. Zouggari Y., Ait-Oufella H., Bonnin P., Simon T., Sage A.P., Guerin C., et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 2013, 19(10):1273-1280.
39. Varda-Bloom N., Leor J., Battler A. Captopril: a new drug for myocardial ischemia and infarction?. Harefuah 1993, 124(9):556-559.
40. Laroumanie F., Douin-Echinard V., Pozzo J., Lairez O., Tortosa F., Vinel C., et al. CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 2014, 129(21):2111-2124.
41. Yan X., Shichita T., Katsumata Y., Matsuhashi T., Ito H., Ito K., et al. Deleterious effect of the IL-23/IL-17 A axis and gammadeltaT cells on left ventricular remodeling after myocardial infarction. J. Am. Heart Assoc. 2012, 1(5):e004408.
42. Nevers T., Salvador A.M., Grodecki-Pena A., Knapp A., Velazquez F., Aronovitz M., et al. Left ventricular T-cell recruitment contributes to the pathogenesis of Heart failure. Circ. Heart Fail. 2015, 8(4):776-787.
43. Saxena A., Dobaczewski M., Rai V., Haque Z., Chen W., Li N., et al. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am. J. Physiol. Heart Circ. Physiol. 2014, 307(8):H1233-H1242.
44. Matsumoto K., Ogawa M., Suzuki J., Hirata Y., Nagai R., Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int. Heart J. 2011, 52(6):382-387.
45. Tang T.T., Yuan J., Zhu Z.F., Zhang W.C., Xiao H., Xia N., et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res. Cardiol. 2012, 107(1):232.
46. Sharir R., Semo J., Shimoni S., Ben-Mordechai T., Landa-Rouben N., Maysel-Auslender S., et al. Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling. PLoS One 2014, 9(12):e113653.
47. Wang Y.P., Xie Y., Ma H., Su S.A., Wang Y.D., Wang J.A., et al. Regulatory T lymphocytes in myocardial infarction: A promising new therapeutic target. Int. J. Cardiol. 2015, 203:923-928.
48. Skorska A., von Haehling S., Ludwig M., Lux C.A., Gaebel R., Kleiner G., et al. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function. J. Cell. Mol. Med. 2015, 19(8):1975-1985.
49. Guzik T.J., Hoch N.E., Brown K.A., McCann L.A., Rahman A., Dikalov S., et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007, 204(10):2449-2460.
50. Kvakan H., Kleinewietfeld M., Qadri F., Park J.K., Fischer R., Schwarz I., et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009, 119(22):2904-2912.
51. Frantz S., Hofmann U., Fraccarollo D., Schafer A., Kranepuhl S., Hagedorn I., et al. Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J. 2013, 27(3):871-881.
52. Kloner R.A., Fishbein M.C., Lew H., Maroko P.R., Braunwald E. Mummification of the infarcted myocardium by high dose corticosteroids. Circulation 1978, 57(1):56-63.
53. Frenkel D., Pachori A.S., Zhang L., Dembinsky-Vaknin A., Farfara D., Petrovic-Stojkovic S., et al. Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. Int. Immunol. 2009, 21(7):817-829.
54. Li J., Goser S., Leuschner F., Volz H.C., Buss S., Andrassy M., et al. Mucosal tolerance induction in autoimmune myocarditis and myocardial infarction. Int. J. Cardiol. 2013, 162(3):245-252.